We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Merck & Co. on Monday announced that Adam Schechter, president of the drugmaker's global human health division, will be stepping down at the end of the year. The company noted that Schechter will be transitioning to an advisory role to CEO Ken Frazier.